The Elisabeth-TweeSteden Hospital
10
4
4
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
10.0%
1 terminated/withdrawn out of 10 trials
66.7%
-19.8% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Multicentre RCT of Awake Versus Asleep Tractography Based DBS for ET
Role: collaborator
Glioblastoma Targeted Treatment Option Maximization by WGS
Role: collaborator
Tilburg Health Outcomes Registry of Emotional Stress in Coronary Intervention
Role: collaborator
Assessing the Effect of the 'Wavy' Application, on Stress and Burden of Disease in Women With INOCA
Role: collaborator
Bifurcation PCI With a Hybrid Strategy With Drug Eluting Balloons Versus a Stepwise Provisional Two-stent Strategy
Role: collaborator
Percutaneous Transforaminal Endoscopic Discectomy vs. Open Microdiscectomy for Lumbar Disc Herniation (PTED-study)
Role: collaborator
CCTA-guided Ultraselective Invasive Coronary Angiography
Role: collaborator
The Permacol Dutch Cohort Study
Role: collaborator
Improving MEDication Adherence in Chronic Heart Failure Using a TELEmedicine Device (TELEMED-HF)
Role: collaborator
TweeSteden Mild Stenosis Study
Role: collaborator
All 10 trials loaded